Article info

Download PDFPDF
Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn’s disease

Authors

  • Bram Verstockt Dpt Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, BelgiumDpt Chronic Diseases, Metabolism and Ageing, Translational Research in Gastrointestinal Disorders (TARGID), IBD, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Liesbeth Boets Dpt Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • João Sabino Dpt Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, BelgiumDpt Chronic Diseases, Metabolism and Ageing, Translational Research in Gastrointestinal Disorders (TARGID), IBD, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Séverine Vermeire Dpt Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, BelgiumDpt Chronic Diseases, Metabolism and Ageing, Translational Research in Gastrointestinal Disorders (TARGID), IBD, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Marc Ferrante Dpt Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, BelgiumDpt Chronic Diseases, Metabolism and Ageing, Translational Research in Gastrointestinal Disorders (TARGID), IBD, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Marc Ferrante, KU Leuven University Hospitals Leuven, Leuven B3000, Belgium; marc.ferrante{at}uzleuven.be
View Full Text

Citation

Verstockt B, Boets L, Sabino J, et al
Thiopurine monotherapy has a limited place in treatment of patients with mild-to-moderate Crohn’s disease

Publication history

  • Received July 27, 2020
  • Revised August 17, 2020
  • Accepted August 24, 2020
  • First published September 14, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.